Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment

Bibliographic Details
Main Author:	Miguel Angel Martinez
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 repurposed drugs treatment efficacy HIV HCV
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.635371/full

Similar Items

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020-11-01)

Editorial: Drug Repurposing for COVID-19 Therapy
by: Rafael Maldonado, et al.
Published: (2021-08-01)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
by: Janet Sultana, et al.
Published: (2020-11-01)

Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data
by: Fadhl M. Alakwaa
Published: (2020-04-01)

Drug Repurposing and Dosage Form Development of Anti-COVID-19
by: Kevin Kwok
Published: (2021-04-01)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
by: Bárbara Costa, et al.
Published: (2021-05-01)

Drug Repurposing Approaches to Combating Viral Infections
by: Jay Trivedi, et al.
Published: (2020-11-01)

A Rapid Strategy for Repurposing Drugs for COVID-19
by: Maryam Khoubnasabjafari, et al.
Published: (2020-11-01)

Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
by: Safaet Alam, et al.
Published: (2021-06-01)

Bayesian Model Infers Drug Repurposing Candidates for Treatment of COVID-19
by: Michael A. Kiebish, et al.
Published: (2021-03-01)

Combating COVID-19: The role of drug repurposing and medicinal plants
by: Shah A. Khan, et al.
Published: (2021-04-01)

Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
by: José Miguel Vela
Published: (2020-11-01)

Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
by: Dan-Yang Liu, et al.
Published: (2021-04-01)

Buying time: Drug repurposing to treat the host in COVID‐19H
by: Jennifer H. Martin, et al.
Published: (2020-08-01)

Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19
by: Paola Stolfi, et al.
Published: (2020-10-01)

Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs
by: Valentina L. Kouznetsova, et al.
Published: (2020-09-01)

Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
by: Rudra P. Saha, et al.
Published: (2020-08-01)

Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach
by: Tamizhini Loganathan, et al.
Published: (2020-06-01)

Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
by: Bruno Silva Andrade, et al.
Published: (2020-12-01)

In silico drug repurposing in COVID-19: A network-based analysis
by: Pasquale Sibilio, et al.
Published: (2021-10-01)

Artificial intelligence approach fighting COVID-19 with repurposing drugs
by: Yi-Yu Ke, et al.
Published: (2020-08-01)

The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience
by: Lucia Gozzo, et al.
Published: (2020-09-01)

A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
by: Kaleb B. Tsegay, et al.
Published: (2021-06-01)

Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
by: Milo Gatti, et al.
Published: (2021-02-01)

Network bioinformatics analysis provides insight into drug repurposing for COVID-19
by: Xu Li, et al.
Published: (2021-06-01)

Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
by: Dina B. Mahmoud, et al.
Published: (2020-07-01)

Repurposing of antibiotics for clinical management of COVID-19: a narrative review
by: Abdourahamane Yacouba, et al.
Published: (2021-05-01)

Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform
by: Kaushik Chakravarty, et al.
Published: (2021-03-01)

Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
by: Charlotte Kern, et al.
Published: (2021-03-01)

Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
by: Andrea Gelemanović, et al.
Published: (2021-01-01)

AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate
by: Marcin Delijewski, et al.
Published: (2021-03-01)

Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19
by: Chen-Tsung Huang, et al.
Published: (2020-12-01)

A COVID-19 Drug Repurposing Strategy through Quantitative Homological Similarities Using a Topological Data Analysis-Based Framework
by: Raul Pérez-Moraga, et al.
Published: (2021-04-01)

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
by: Xinlei Li, et al.
Published: (2021-05-01)

COVID-19: Ivermectin; Molecular Mechanisms, Limitations, Suggestions
by: Mustafa KESMEN, et al.
Published: (2020-12-01)

Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19
by: Xianfang Tang, et al.
Published: (2021-01-01)

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)

Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach
by: Mahmudul Hasan, et al.
Published: (2021-08-01)

Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review
by: Fui Fui Lem, et al.
Published: (2021-02-01)

Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19
by: Daniel P. Smith, et al.
Published: (2021-07-01)